Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages

x

This content is available also in other languages


Tecan Journal

Selected category: IVD

Back to overview

Delivering end-to-end traceability

Laboratories working in the field of in vitro diagnostics (IVD) must comply with increasing accreditation requirements that may vary from country to country. For US-based Inova Diagnostics, the challenge was to provide a family of automated platforms that make it easy for labs to conform with accreditation requirements for autoimmune testing.

Read more

Capturing the IVD market in China

In vitro diagnostics (IVD) is central to the provision of healthcare globally, and is estimated to be worth in excess of $8.2 billion (€7.3 billion) a year in China alone.1 Despite this, the Chinese IVD landscape has historically been controlled by large international providers, with few domestic instrumentation and assay suppliers. Start-up company Shenzen AiTe is looking to change this, with the development of diagnostic platforms and assays offering rapid detection for a wide range of blood-based markers.

Read more
empty cart | close cart
Your cart

Your cart is empty.

Get a quote close form